Integrin inhibitors from snake venom: Exploring the relationship between the structure and activity of RGD-peptides

Archives of Biochemistry and Biophysics

Volumn 482, Issue 1-2, 2009, Pages 25-32

  Wermelinger, Luciana S ^a   Geraldo, Reinaldo B ^b   Frattani, Flavia S ^a   Rodrigues, Carlos R ^a   Juliano, Maria A ^c   Castro, Helena C ^b   Zingali, Russolina B ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Aggregation; Disintegrin; Inhibitor; Integrin; Jararacin; Jarastatin; Molecular modeling; Platelet; Receptor; RGD peptide

Indexed keywords

ADENOSINE DIPHOSPHATE; ARGINYLGLYCYLASPARTIC ACID; BATROXOBIN; CYCLOPEPTIDE; DISINTEGRIN; INTEGRIN; INTEGRIN ALPHA2B BETA3; JARARACIN; JARASTATIN; SNAKE VENOM; THROMBIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; HUMAN; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; STRUCTURE ACTIVITY RELATION; THROMBOCYTE AGGREGATION;

AMINO ACID SEQUENCE; ANIMALS; BOTHROPS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROTALID VENOMS; DISINTEGRINS; HUMANS; INTEGRINS; OLIGOPEPTIDES; PEPTIDES; PLATELET AGGREGATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; THROMBIN;

BOTHROPS JARARACA;

EID: 59149096335     PISSN: 00039861     EISSN: 10960384     Source Type: Journal    
DOI: 10.1016/j.abb.2008.11.023     Document Type: Article

References (40)

1. Humphries M.J. Biochem. Soc. Trans. 28 (2000) 311-339
2. Shattil S.J., and Newman P.J. Blood 104 (2004) 1606-1615
3. Plow E.F., Cierniewski C.S., Xiao Z., Haas T.A., and Byzova T.V. Thromb. Haemost. 86 (2001) 34-40
4. Jackson S.P., and Schoenwaelder S.M. Nat. Rev. Drug Discov. 2 (2003) 775-789
5. Calvete J.J., Fox J.W., Agelan A., Niewiarowski S., and Marcinkiewicz C. Biochemistry 41 (2002) 2014-2021
6. Kim J., Hong S.Y., Park H.S., Kim D.S., and Lee W. Mol. Cells. 19 (2005) 205-211
7. Markland F.S. Toxicon 36 (1998) 1749-1800
8. Fujimoto T., and Hawiger J. Nature 297 (1982) 154-156
9. Plow E.F., and Ginsberg M.H. J. Biol. Chem. 256 (1981) 9477-9482
10. Shimaoka M., and Springer T.A. Nat. Rev. Drug Discov. 2 (2003) 703-716
11. Calvete J.J., Marcinkiewicz C., Monleón D., Esteve V., Celda B., Juárez P., and Sanz L. Toxicon 45 (2005) 1063-1074
12. McLane M.A., Sanchez E.E., Wong A., Paquette-Straub C., and Perez J.C. Curr. Drug Targets Cardiovasc. Haematol. Disord. 4 (2004) 327-355
13. S. Niewiarowski, C. Marcinkiewicz, I. Wierzbicka-Patynowski, M.A. McLane, J.J. Calvete, Perspectives in Molecular Toxinology, England, 2002 (pp. 327-339).
14. Cidade D.A.P., Wermelinger L.S., Lôbo-Hajdu G., Dávila A.M.R., Bon C., Zingali R.B., and Albano R.M. Toxicon 48 (2006) 590-599
15. Scarborough R.M., Rose J.W., Naughton M.A., Phillips D.R., Nannizzi L., Arfsten A., Campbell A.M., and Charo I.F. J. Biol. Chem. 268 (1993) 1058-1065
16. Coelho A.L.J., Freitas M.S., Oliveira-Carvalho A.L., Moura-Neto V., Zingali R.B., and Barja-Fidalgo C. Exp. Cell Res. 251 (1999) 379-387
17. Prévost N., Kato H., Bodin L., and Shattil S.J. Methods Enzymol. 426 (2007) 103-115
18. Ngai P.K., and Chang J.Y. Biochem. J. 280 (1991) 805-808
19. Bradford M.M. Anal. Biochem. 7 (1976) 48-54
20. Wermelinger L.S., Dutra D.L., Oliveira-Carvalho A.L., Soares Jr. M.R., Bloch C., and Zingali R.B. Rapid commun. Mass Spectrom. 19 (2005) 1703-1708
21. Born G.V.R., and Cross M.J. J. Physiol. 168 (1963) 178-195
22. Soslau G., Class R., Morgan D.A., Foster C., Lord S.T., Marchese P., and Ruggeri Z.M. J. Biol. Chem. 276 (2001) 21173-21183
23. Thompson J.D., Higgins D.G., and Gibson T.J. Nucleic Acids Res. 22 (1994) 4673-4680
24. Abreu P.A., Albuquerque M.G., Rodrigues C.R., and Castro H.C. Toxicon 48 (2006) 690-701
25. Guex N., and Peitsch M.C. Electrophoresis 18 (1997) 2714-2723
26. Schwede T., Kopp J., Guex N., and Peitsch M.C. Nucleic Acids Res. 31 (2003) 3381-3385
27. Castro H.C., Silva D.M., Craik C., and Zingali R.B. Biochim. Biophys. Acta. 1547 (2001) 183-195
28. Xu D., Lin S.L., and Nussinov R. J. Mol. Biol. 265 (1997) 68-84
29. Shin J., Hong S.Y., Chung K., Kang I., Jang Y., Kim D.S., and Lee W. Biochemistry 42 (2003) 14408-14415
30. Fujii Y., Okuda D., Fujimoto Z., Horii K., Morita T., and Mizuno H. J. Mol. Biol. 332 (2003) 1115-1122
31. Wijeyewickrema L.C., Berndt M.C., and Andrews R.K. Toxicon 45 (2005) 1051-1061
32. Chang C.P., Chang J.C., Chang H.H., Tsai W.J., and Lo S.J. Biochem. J. 357 (2001) 57-64
33. Maruyama K., Kawasaki T., Sakai Y., Taniuchi Y., Shimizu M., Kawashima H., and Takenaka T. Peptides 18 (1997) 73-78
34. Okuda D., and Morita T. J. Biochem. 130 (2001) 407-415
35. Hong S.Y., Koh Y.S., Chung K.H., and Kim D.S. Thromb. Res. 105 (2002) 79-86
36. Kang I.C., Chung K.H., Lee S.J., Yun Y., Moon H.M., and Kim D.S. Thromb. Res. 91 (1998) 65-73
37. Marcinkiewicz C. Curr. Pharm. Des. 11 (2005) 815-827
38. Charo I.F., Fitzgerald L.A., Steiner B., Rall Jr. S.C., Bekeart L.S., and Phillips D.R. Proc. Natl. Acad. Sci. 83 (1986) 8351-8355
39. Rahman S., Aitken A., Flynn G., Formstone C., and Savidge G.F. Biochem. J. 335 (1998) 247-257
40. Xiao T., Takagi J., Coller B.S., Wang J.H., and Springer T.A. Nature 432 (2004) 59-67